Company intelligence / Profile preview

Apollo Cannabis Clinics

North York, Ontario, Canada

Ownership: Private
Employees: ~31
Development stage: Other

Overview

Research study of 751 chronic pain patients showed significant improvements in pain severity, mental health, and overall quality of life. Patients reported a statistically significant 95% reduction in opioid use following 12 months of medical cannabis use. The clinic operates one of Canada's largest medical cannabis studies with phase 3-4 clinical trials and observational studies.

Therapeutic areas: PsychiatryNeurologyOncology
Modalities: Phytopharmaceutical (medical cannabis products)
Industry: Non-Academic Healthcare

Partnerships

University of GuelphUniversity of TorontoNew York UniversityHealth Canada

Beyond the preview

Go deeper on Apollo Cannabis Clinics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apollo Cannabis Clinics.

Explore the full profile